IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q3 2015 Holdings

Filed 2015-11-16 | 18 holdings | $87.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc.(ABBV)COM00287Y109$86.0M1,580,00098.2%
ANI Pharmaceuticals Inc(ANIP)COM00182C103$1.2M31,0001.4%
Ariad Pharmaceuticals IncCOM04033A100$75.0K12,850,0000.1%
Medicines CoCOM584688105$59.5K1,567,0000.1%
Quest Diagnostics Inc(DGX)COM74834L100$35.3K575,0000.0%
Aegerion Pharmaceuticals IncCOM00767E102$34.7K2,555,0000.0%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$25.6K640,0000.0%
Merck & Co Inc New(MRK)COM58933Y105$19.8K400,0000.0%
Pacira Pharmaceuticals Inc(PCRX)COM695127100$15.6K380,0000.0%
Amgen Inc(AMGN)COM031162100$12.4K90,0000.0%
Esperion Therapeutics Inc NE(ESPR)COM29664W105$10.6K448,0000.0%
Apricus Biosciences IncCOM03832V109$9.5K6,524,5050.0%
Repros Therapeutics IncCOM NEW76028H209$8.4K1,132,3670.0%
Vivus IncCOM928551100$4.2K2,573,9430.0%
Kindred Biosciences IncCOM494577109$3.6K689,0910.0%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$2.8K2,313,7590.0%
Catalyst Biosciences Inc.COM14888D109$41990,0000.0%
Eleven Biotherapeutics IncCOM286221106$9941,2000.0%